Registration

BRADEN PARTNERS, LP D/B/A PACIFIC PULMONARY SERVICES for BRADEN PARTNERS, LP D/B/A PACIFIC PULMONARY SERVICES

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 621 / S. 1484, Home Oxygen Patient Protection Act of 2007 -- home oxygen therapy issues including repeal of title transfer; H.R. 3162, Children's Health and Medicare Protection (CHAMP) Act of 2007 -- home oxygen therapy reimbursement; S. 2499, Medicare, Medicaid and SCHIP Extension Act of 2007; S. 3101 / S. 6331, Medicare Improvements for Patients and Providers Act of 2008; H.R. 6252 / S. 3144, Medicare DMEPOS Competitive Acquisition Reform Act of 2008

LobbyistCovered position, as disclosed
ANNA KATHERINE WEINSTEIN New Paid Intern, Office of Senator Patrick Leahy (D-VT)

Bills named: S. 3101 (110th), S. 6331 (110th), S. 1484 (110th), S. 3144 (110th), H.R. 6252 (110th), H.R. 621 (110th), S. 2499 (110th), H.R. 3162 (110th)

Health Issues HCR

H.R. 621 / S. 1484, Home Oxygen Patient Protection Act of 2007 -- home oxygen therapy issues including repeal of title transfer; H.R. 3162, Children's Health and Medicare Protection (CHAMP) Act of 2007 -- home oxygen therapy reimbursement; S. 2499, Medicare, Medicaid and SCHIP Extension Act of 2007; S. 3101 / S. 6331, Medicare Improvements for Patients and Providers Act of 2008; H.R. 6252 / S. 3144, Medicare DMEPOS Competitive Acquisition Reform Act of 2008

LobbyistCovered position, as disclosed
ANNA KATHERINE WEINSTEIN New Paid Intern, Office of Senator Patrick Leahy (D-VT)

Bills named: S. 6331 (110th), S. 1484 (110th), H.R. 621 (110th), S. 2499 (110th), H.R. 3162 (110th), H.R. 6252 (110th), S. 3144 (110th), S. 3101 (110th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
TEIJIN PHARMA LIMITED (SEE NOTE ON NEXT PAGE) Japan Japan 100.0% —
TEIJIN HOLDING USA INC. / TEIJIN PHARMA USA LLC (INTERMED.) United States United States 100.0% —
JAPANESE PRINCIPAL OWNS INTERM. US CO'S WHICH JOINTLY OWN BRADEN Japan Japan 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.